These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1351502)

  • 1. Induction and suppression of delayed-type hypersensitivity to non-MHC antigens during lethal graft-versus-host reaction.
    Pritchard LL; Huchet R; Bruley-Rosset M; Riché N; Mishal Z; Halle-Pannenko O
    J Immunol; 1992 Jul; 149(1):45-52. PubMed ID: 1351502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mlsa generated suppressor cells. I. Suppression is mediated by double-negative (CD3+CD5+CD4-CD8-) alpha/beta T cell receptor-bearing cells.
    Bruley-Rosset M; Miconnet I; Canon C; Halle-Pannenko O
    J Immunol; 1990 Dec; 145(12):4046-52. PubMed ID: 1701781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
    Matsushima GK; Stohlman SA
    J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL; Atasoylu AA
    Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens.
    Miconnet I; Bruley-Rosset M; Halle-Pannenko O
    J Immunol; 1992 Jun; 148(12):3706-13. PubMed ID: 1534822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
    Halle-Pannenko O; Pritchard LL; Rappaport H
    Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-host mortality induced by noncytolytic CD4+ T cell clones specific for non-H-2 antigens.
    Miconnet I; Huchet R; Bonardelle D; Motta R; Canon C; Garay-Rojas E; Kress M; Reynes M; Halle-Pannenko O; Bruley-Rosset M
    J Immunol; 1990 Oct; 145(7):2123-31. PubMed ID: 1697877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors.
    Herzog WR; Ferreri NR; Ptak W; Askenase PW
    J Immunol; 1989 Nov; 143(10):3125-33. PubMed ID: 2478617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD; Becker EE; Truitt RL
    Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of the lethal graft-vs.-host reaction developed to non-H-2 antigens: involvement of T suppressor cells distinct from veto cells.
    Halle-Pannenko O; Pritchard LL; Bruley-Rosset M
    Eur J Immunol; 1987 Dec; 17(12):1751-5. PubMed ID: 2961574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
    Korngold R
    Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment.
    Fowler DH; Kurasawa K; Husebekk A; Cohen PA; Gress RE
    J Immunol; 1994 Feb; 152(3):1004-13. PubMed ID: 7905495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
    Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
    Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids.
    Krzystyniak K; Panaye G; Descotes J; Revillard JP
    Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of delayed-type hypersensitivity. VII. The role of I-J subregion gene products in the inhibition of delayed-type hypersensitivity to major histocompatibility antigens by specific suppressor T cells.
    Liew FY
    Eur J Immunol; 1981 Nov; 11(11):883-8. PubMed ID: 6173227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M; Wettstein PJ; Korngold R
    Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effect.
    de la Selle V; Miconnet I; Gilbert D; Bruley-Rosset M
    Bone Marrow Transplant; 1995 Jul; 16(1):111-8. PubMed ID: 7581109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
    Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
    Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.